Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 29% ± 11% | |
peripheral blood | 16 studies | 31% ± 11% | |
brain | 16 studies | 50% ± 23% | |
eye | 10 studies | 32% ± 12% | |
intestine | 7 studies | 25% ± 10% | |
kidney | 5 studies | 24% ± 4% | |
heart | 5 studies | 22% ± 4% | |
bone marrow | 4 studies | 30% ± 10% | |
lymph node | 4 studies | 28% ± 11% | |
breast | 4 studies | 20% ± 3% | |
liver | 4 studies | 38% ± 11% | |
adipose | 4 studies | 35% ± 10% | |
placenta | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5139.73 | 1445 / 1445 | 100% | 22.63 | 183 / 183 |
lung | 100% | 5989.64 | 578 / 578 | 100% | 23.42 | 1153 / 1155 |
brain | 100% | 5641.84 | 2639 / 2642 | 100% | 22.88 | 704 / 705 |
breast | 100% | 6004.30 | 459 / 459 | 100% | 35.41 | 1114 / 1118 |
uterus | 100% | 6132.49 | 170 / 170 | 100% | 19.17 | 457 / 459 |
pancreas | 100% | 3056.56 | 327 / 328 | 99% | 16.80 | 177 / 178 |
thymus | 100% | 5751.04 | 653 / 653 | 99% | 16.04 | 598 / 605 |
bladder | 100% | 6014.57 | 21 / 21 | 99% | 17.76 | 498 / 504 |
prostate | 100% | 6143.84 | 245 / 245 | 99% | 15.07 | 495 / 502 |
intestine | 100% | 5960.20 | 966 / 966 | 98% | 15.38 | 516 / 527 |
ovary | 100% | 8248.71 | 180 / 180 | 98% | 12.47 | 420 / 430 |
stomach | 100% | 4376.77 | 359 / 359 | 98% | 17.51 | 279 / 286 |
skin | 100% | 5371.09 | 1808 / 1809 | 96% | 15.20 | 452 / 472 |
kidney | 100% | 3526.09 | 89 / 89 | 95% | 11.99 | 856 / 901 |
adrenal gland | 100% | 3375.52 | 258 / 258 | 93% | 11.69 | 213 / 230 |
liver | 99% | 1715.02 | 223 / 226 | 49% | 4.39 | 200 / 406 |
adipose | 100% | 5602.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6024.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.34 | 29 / 29 |
spleen | 100% | 5447.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.44 | 1 / 1 |
muscle | 99% | 2434.09 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2525.98 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 4094.01 | 901 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 13.46 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0032259 | Biological process | methylation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0140951 | Molecular function | histone H3K27 trimethyltransferase activity |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0046975 | Molecular function | histone H3K36 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0140537 | Molecular function | transcription regulator activator activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0140946 | Molecular function | histone H3K4 dimethyltransferase activity |
GO_0140952 | Molecular function | histone H3K27 dimethyltransferase activity |
Gene name | NSD3 |
Protein name | Nuclear receptor binding SET domain protein 3 Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1) |
Synonyms | DC28 WHSC1L1 |
Description | FUNCTION: Histone methyltransferase. Preferentially dimethylates 'Lys-4' and 'Lys-27' of histone H3 forming H3K2me2 and H3K27me2. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation, while 'Lys-27' is a mark for transcriptional repression. . |
Accessions | E9PKL3 ENST00000534539.1 ENST00000534155.1 H0YE68 ENST00000433384.6 [Q9BZ95-2] E9PQ95 ENST00000528627.1 ENST00000317025.13 [Q9BZ95-1] ENST00000529223.1 ENST00000316985.7 [Q9BZ95-3] ENST00000527502.5 [Q9BZ95-5] E9PKA2 Q9BZ95 |